As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why. Short-selling firm Hindenburg ...

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

"Respiratory illness activity is high in Kentucky," the Kentucky Department for Public Health reported Thursday, and "emergency department and inpatient encounters for acute respiratory illness are ...

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Dylan Lewis: We're talking three stocks down bad. Motley Fool Money starts down. I'm Dylan Lewis, I'm joined over the ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...